Search For "cipla"
Sensex rallies 288 points, pharma and banking stocks gain
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], Sep 15 (ANI): Equity benchmark indices closed with an upward bounce on Tuesday as a sharp rally was witnessed in select mid-cap stocks for the second consecutive trading session.
Read More
Equities in the green with thin margins, pharma majors gain
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 15 (ANI): Equity benchmark indices traded higher with narrow gains during early hours on Tuesday amid positive sentiment across global markets.
Read More
Equity indices close flat, pharma stocks hit but PSU banks gain
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 12 (ANI): Equity benchmark indices erased early losses but lay flat in the negative terrain at close on Wednesday with pharma stocks remaining under pressure.
Read More
Equity indices dip on weak global cues, pharma stocks hit
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 12 (ANI): Equity benchmark indices drifted lower during early hours on Wednesday amid weak global cues with pharma stocks losing the most.
Read More
Equity indices close in the green, Cipla gains 9.5 pc
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 10 (ANI): Equity benchmark indices shaved off early gains but ended in the positive terrain on Monday with pharma stocks leading the rally.
Read More
Equity indices trade higher, pharma and auto stocks gain
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 10 (ANI): Equity benchmark indices advanced by 0.8 per cent during early hours on Monday with pharma, auto and financial stocks in the lead.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload details of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
Sensex closes 180 points up, Glenmark Pharma jumps 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices wiped out early gains but closed over half a per cent higher on Monday led by gains in banking, pharma and metal stocks.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Equity indices trade higher as banking, pharma stocks rally
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices rose by nearly 1 per cent during early hours on Monday led by gains in banking, pharma and metal stocks.
Read More